Vanguard Trims USANA Health Sciences Stake to 5.7%

TL;DR

**Vanguard just cut its USANA stake to 5.7%, a minor passive adjustment.**

AI Summary

The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership in USANA Health Sciences Inc. As of December 29, 2023, Vanguard holds 1,069,825 shares of USANA's Common Stock, representing 5.7% of the company. This is a slight decrease from their previous reported stake, indicating a minor adjustment in their passive investment strategy.

Why It Matters

This filing shows that a major institutional investor, Vanguard, has slightly reduced its position in USANA, which could signal a minor shift in their outlook or portfolio rebalancing, potentially influencing other investors.

Risk Assessment

Risk Level: low — The change in ownership is minor and from a passive institutional investor, indicating no significant immediate risk to the company or its stock.

Analyst Insight

Investors should note Vanguard's slight reduction as a passive portfolio adjustment rather than a strong bearish signal, but monitor future institutional filings for more significant changes in sentiment.

Key Numbers

• 1,069,825 — Shares Owned (The total number of USANA Health Sciences Inc. Common Stock shares beneficially owned by The Vanguard Group as of December 29, 2023.)
• 5.7% — Ownership Percentage (The percentage of USANA Health Sciences Inc. Common Stock owned by The Vanguard Group, indicating their significant but passive stake.)

Key Players & Entities

• The Vanguard Group (company) — reporting person and institutional investor
• USANA Health Sciences Inc (company) — subject company whose securities are being reported
• 1,069,825 (dollar_amount) — number of shares of Common Stock beneficially owned by Vanguard
• 5.7% (dollar_amount) — percentage of USANA's class of securities owned by Vanguard
• December 29, 2023 (date) — date of the event requiring the filing

Forward-Looking Statements

• Vanguard will maintain a significant, passive stake in USANA Health Sciences Inc. (The Vanguard Group) — high confidence, target: Next 12 months

FAQ

From the Filing

0001104659-24-022203.txt : 20240213 0001104659-24-022203.hdr.sgml : 20240213 20240213171600 ACCESSION NUMBER: 0001104659-24-022203 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-55565 FILM NUMBER: 24629769 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: VANGUARD GROUP INC CENTRAL INDEX KEY: 0000102909 ORGANIZATION NAME: IRS NUMBER: 231945930 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: PO BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482-2600 BUSINESS PHONE: 6106691000 MAIL ADDRESS: STREET 1: PO BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482-2600 SC 13G/A 1 tv02181-usanahealthsciencesi.htm SCHEDULE 13G/A usanahealthsciencesinc SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer:  USANA Health Sciences Inc Title of Class of Securities:  Common Stock CUSIP Number:  90328M107 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule 13d-1(c) ☐ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on the following page(s))     13G CUSIP No.:  90328M107 1.  NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON The Vanguard Group - 23-1945930 2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP A.  B.  X 3.  SEC USE ONLY 4.  CITIZENSHIP OF PLACE OF ORGANIZATION Pennsylvania (For questions 5-8, report the number of shares beneficially owned by each reporting person with:) 5.  SOLE VOTING POWER 0 6.  SHARED VOTING POWER 20,386 7.  SOLE DISPOSITIVE POWER 1,549,646 8.  SHARED DISPOSITIVE POWER 33,096 9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,582,742 10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES N/A 11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.27% 12.  TYPE OF REPORTING PERSON IA     SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Act of 1934 Item 1(a) - Name of Issuer: USANA Health Sciences Inc Item 1(b) - Address of Issuer's Principal Executive Offices: 3838 West Parkway Boulevard Salt Lake City, UT 84120 Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930 Item 2(b) – Address of Principal Business Office or, if none, residence: 100 Vanguard Blvd. Malv